References
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):417–496.
- Cappellini MD, Cohen A, Eleftheriou A, et al. Guidelines for the Clinical Management of Thalassaemia, 2nd rev ed. Nicosia (Cyprus): Thalassaemia International Federation, 2008.
- el-Danasoury AS, Eissa DG, Abdo RM, et al. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion. 2012;52(1):43–47.
- Mokhtar GM, Gadallah M, NHK ES, et al. Morbidities and mortality in transfusion-dependent β-thalassemia patients (single-center experience. Pediatr Hematol Oncol. 2013;30(2):92–103.
- Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5:13
- Kyriacou K, Kyrri A, Kalogirou E, et al. Hb Bart's levels in cord blood and α-thalassaemia mutations in Cyprus. Hemoglobin. 2000;24(3):171–180.
- Faulkner LB, Uderzo C, Masera G. International cooperation for the cure and prevention of severe hemoglobinopathies. J Pediatr Hematol Oncol. 2013;35(6):419–423.
- Huang S-W, Xu Y, Liu X-M, et al. The prevalence and spectrum of α-Thalassemia in Guizhou Province of South China. Hemoglobin. 2015;39(4):260–263.
- Novelletto A, Hafez M, Di Rienzo A, et al. Frequency and molecular types of deletional α-thalassemia in Egypt. Hum Genet. 1989;81(3):211–213.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
- Bowden DK, Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of α-thalassaemia. Br J Haematol. 1992;81(1):104–108.
- Al Qaddoumi A, Kamal N, Shbailat T. Molecular spectrum of α-thalassemia in Jordan. J Res Med Sci. 2008;15(5):23–27.
- Rosnah B, Rosline H, Zaidah AW, et al. Detection of common deletional α-thalassemia spectrum by molecular technique in Kelantan, northeastern Malaysia. ISRN Hematol. 2012;2012:1.
- Leung WC, Leung KY, Lau ET, et al. β-thalassaemia. Semin Fetal Neonatal Med. 2008;13(4):215–222.
- George E, Ann TJ. Genotype-phenotype diversity of β-thalassemia in Malaysia: treatment options and emerging therapies. Med J Malaysia. 2010;65(4):256–260.
- Singh SP, Gupta SC. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting β-thalassaemia trait. Singapore Med J. 2008;49(10):823–826.
- Polat G, Yüregir GT, Aksoy K. Detection of deletional α thalassemia in Cükürova. Ann Med Health Sci. 1998;7(4):14–17.
- Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005;1054:18–24.
- Hemoglobin-α Locus 1 Center for Arab Genomic studies (CAGS). Available from http://www.cags.org.ae/pdf/141800.pdf, accessed online on January 22 2009.
- El-Beshlawy A, El-Shekha A, Momtaz M, et al. Prenatal diagnosis for thalassaemia in Egypt: what changed parents' attitude? Prenat Diagn. 2012;32(8):777–782.
- El-Beshlawy A, Kaddah N, Mostafa A, et al. Screening of β thalassemia carriers in Egypt: significance of osmotic fragility test. East Mediterr Health J. 2007;13(4):780–786.
- Keikhaei B, Slehi-Fard P, Shariati G, et al. Genetics of Iranian α-thalassamia patients: a comprehensive original study. Biochem Genet. 2018;56(5):506–521.
- Denic S, Agarwal MM, Al Dabbagh B, et al. Hemoglobin A2 lowered by iron deficiency and α-thalassemia: should screening recommendation for β-thalassemia change? ISRN Hematol. 2013;2013:858294.
- Vichinsky E. Advances in the treatment of α-thalassemia. Blood Rev. 2012;26(Suppl 1):S31–S34.
- Tang DC, Fucharoen S, Ding I, et al. Rapid differentiation of five common α-thalassemia genotypes by polymerase chain reaction. J Lab Clin Med. 2001;137(4):290–295.
- Weatherall D, Clegg J, Kwiatkowski D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res. 1997;7(10):967–973.